Insulin Resistance, Diabetes
9
1
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
85.7%
-0.8% vs benchmark
11%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise
Diabetes, Insulin Resistance and Body Composition
Topical Insulin for Postoperative Wound Healing
Duality of Lipids: the Athlete's Paradox
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
Validation of a Novel Screening Test for Maternal Insulin Resistance
Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans
Regulation of Endogenous Glucose Production by Brain Insulin Action